Tau/MAP6 ratio as a master switch for microtubule dynamics plasticity

Mechanistic description

The relative abundance of tau versus MAP6 on individual microtubules determines the balance between stable and labile domains, creating a spatial code for where dynamic remodeling (axon guidance, branching) versus stable support (process integrity) occurs

Prediction: Manipulating the tau:MAP6 expression ratio will shift the entire spectrum of neuronal plasticity phenotypes in a predictable dose-response manner

Mechanism / pathway

MAPT
→
neurodegeneration

Evidence for (5)

Antagonistic roles of tau and MAP6 in regulating neuronal development.

PMID:39257379 2024 J Cell Sci
Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W.

PMID:40044789 2025 Nat Struct Mol Biol
MAPT mutations, tauopathy, and mechanisms of neurodegeneration.

PMID:30742061 2019 Lab Invest
Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease.

PMID:36843263 2023 Autophagy
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

PMID:37095250 2023 Nat Med

Evidence against (2)

PMID:9600916 Denarier E et al., Proc Natl Acad Sci U S A 1998 May 26
PMID:12231625 Andrieux A et al., Genes Dev 2002 Sep 15

Evidence matrix

6 supporting 0 contradicting

100% supporting

Supporting

The relative abundance of tau versus MAP6 on individual microtubules determines the balance between stable and labile domains, creating a spatial code for where dynamic remodeling (axon guidance, branching) versus stable support (process integrity) occurs
Antagonistic roles of tau and MAP6 in regulating neuronal development. PMID:39257379 · 2024 · J Cell Sci
Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W. PMID:40044789 · 2025 · Nat Struct Mol Biol
MAPT mutations, tauopathy, and mechanisms of neurodegeneration. PMID:30742061 · 2019 · Lab Invest
Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease. PMID:36843263 · 2023 · Autophagy
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. PMID:37095250 · 2023 · Nat Med

Contradicting

No contradicting evidence recorded.

Cite this hypothesis

Citation

etl-backfill (2026). Tau/MAP6 ratio as a master switch for microtubule dynamics plasticity. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-c704dd991041

BibTeX

@misc{scidex_hypothesis_hc704dd9,
  title        = {Tau/MAP6 ratio as a master switch for microtubule dynamics plasticity},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-c704dd991041},
  note         = {SciDEX artifact hypothesis:h-c704dd991041}
}